Greenwood Serves Notice To CMS On Image-Guided Breast Biopsy Payments
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Medicare & Medicaid Services should provide an explanation of the data and process by which it set reimbursement levels for image-guided breast biopsy procedures to the House Commerce Committee by Oct. 30, Rep. Jim Greenwood (R-Penn.) states in an Oct. 16 letter to administrator Tom Scully.
You may also be interested in...
J&J Cites Stents, Orthopedics As Key To 9.3% Advance In Q3 Device Sales
Johnson & Johnson cited its DePuy orthopedics and Cordis cardiovascular units as key contributors to a 9.3% advance in its Medical Devices and Diagnostics segment sales to $2.78 bil. for the third quarter, announced Oct. 16.
J&J Cites Stents, Orthopedics As Key To 9.3% Advance In Q3 Device Sales
Johnson & Johnson cited its DePuy orthopedics and Cordis cardiovascular units as key contributors to a 9.3% advance in its Medical Devices and Diagnostics segment sales to $2.78 bil. for the third quarter, announced Oct. 16.
Percutaneous Image-Guided Breast Biopsy To Receive Unique Coding By April
Percutaneous image-guided breast biopsy procedures will be assigned unique payment and coding by the Health Care Financing Administration by April 2000, agency staffers predict following the release of a Medicare coverage decision memorandum.